Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response
Christopher Garris, Jason J. Luke
Clinical Cancer Research (2020) Vol. 26, Iss. 15, pp. 3901-3907
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Jiaqi Liu, Qing Xiao, Jiani Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1188
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 4, pp. 677-688
Open Access | Times Cited: 213
The role of dendritic cells in cancer and anti-tumor immunity
Ariel E. Marciscano, Niroshana Anandasabapathy
Seminars in Immunology (2021) Vol. 52, pp. 101481-101481
Open Access | Times Cited: 168
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 142
A Biomimetic Aggregation‐Induced Emission Photosensitizer with Antigen‐Presenting and Hitchhiking Function for Lipid Droplet Targeted Photodynamic Immunotherapy
Xiuli Xu, Guanjun Deng, Zhihong Sun, et al.
Advanced Materials (2021) Vol. 33, Iss. 33
Closed Access | Times Cited: 126
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
Pengju Gong, You-Cheng Shao, Yan Yang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 95
Next-generation therapies for adrenocortical carcinoma
Barbara Altieri, Cristina L. Ronchi, Matthias Kroiß, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2020) Vol. 34, Iss. 3, pp. 101434-101434
Closed Access | Times Cited: 82
High‐Z‐Sensitized Radiotherapy Synergizes with the Intervention of the Pentose Phosphate Pathway for In Situ Tumor Vaccination
Yuxiang Wang, Jing Chen, R. Duan, et al.
Advanced Materials (2022) Vol. 34, Iss. 13
Closed Access | Times Cited: 64
Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
Christopher Garris, Jeffrey L. Wong, Jeffrey V. Ravetch, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 594
Open Access | Times Cited: 58
Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy
Li Ye, Xiaomin Wang, Xiaoran Ma, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 56
Roles of CD4+ T cells as mediators of antitumor immunity
Dmitriy Kravtsov, Amy K. Erbe, Paul M. Sondel, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy
Pei Pei, Yu Zhang, Yunchun Jiang, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 11325-11337
Closed Access | Times Cited: 45
Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes
Zhengwei Cao, Xueyuan Yang, Wei Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 10, pp. 7618-7632
Open Access | Times Cited: 12
Metal-Phenolic Vehicles Potentiate Cycle-Cascade Activation of Pyroptosis and cGAS-STING Pathway for Tumor Immunotherapy
Weikai Sun, Hong Wang, Yafei Qi, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23727-23740
Closed Access | Times Cited: 12
Engineered algae microrobots as photosynthetic living materials promote T cells’ anti-tumor immunity
Fanqiang Meng, Lin Zhong-da, Yumeng Ma, et al.
Cell Reports Physical Science (2024) Vol. 5, Iss. 6, pp. 102023-102023
Open Access | Times Cited: 11
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Tzu-Yi Chia, Leah K. Billingham, Lauren Boland, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Madhav Sharma, Rafał Pacholczyk, Huidong Shi, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2354-2371.e8
Open Access | Times Cited: 52
The Interplay between the Immune and the Endocannabinoid Systems in Cancer
Mariantonia Braile, Simone Marcella, Gianni Marone, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1282-1282
Open Access | Times Cited: 42
Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity
Yong Liang, Raquibul Hannan, Yang‐Xin Fu
Clinical Cancer Research (2021) Vol. 27, Iss. 14, pp. 3818-3824
Open Access | Times Cited: 41
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
Fotis Nikolos, Kazukuni Hayashi, Xen Ping Hoi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Immunomodulatory effect of locoregional therapy in the tumor microenvironment
Lin Xie, Zhiqiang Meng
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 951-969
Open Access | Times Cited: 19
CCL21/CCR7 axis as a therapeutic target for autoimmune diseases
Le Han, Lingling Zhang
International Immunopharmacology (2023) Vol. 121, pp. 110431-110431
Closed Access | Times Cited: 19
Combining High-Z Sensitized Radiotherapy with CD73 Blockade to Boost Tumor Immunotherapy
Qian Chen, Jing Chen, Qingqing Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12087-12100
Closed Access | Times Cited: 16
Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma
Chan Xiang, Min Zhang, Zhanxian Shang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top